|
Volumn 59, Issue SUPPL. 1, 2000, Pages
|
Arguments for interleukin 1 as a target in chronic arthritis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INTERLEUKIN 1;
INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
INTERLEUKIN 17;
INTERLEUKIN 1BETA;
TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR ANTIBODY;
ANIMAL MODEL;
BONE EROSION;
CARTILAGE DEGENERATION;
CHRONIC ARTHRITIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CYTOKINE PRODUCTION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG TARGETING;
EDEMA;
HUMAN;
IMMUNE COMPLEX DISEASE;
NONHUMAN;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SYNOVIUM;
ANIMALS;
ARTHRITIS, RHEUMATOID;
BONE RESORPTION;
CARTILAGE, ARTICULAR;
DISEASE MODELS, ANIMAL;
HUMANS;
INTERLEUKIN-1;
MICE;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0033764203
PISSN: 00034967
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (85)
|
References (32)
|